Each year, Americans donate billions to fight cancer—yet diagnoses and deaths keep rising. Where is the money going?

The 10 deadliest cancers share one thing: a common metabolic driver. Learn how repurposed drugs can help stop them, and download the free guide by Dr. Paul Marik and Dr. Justus R. Hope.

You’ve got to hand it to the government. For a system that’s historically been about as nurturing as a cactus in a snowstorm, it’s somehow managed to develop a tender, almost maternal instinct to try to save us from ourselves. (*But only sometimes.)

Wormwood is a traditional herbal remedy that has many clinical uses in our modern world. Join us to learn more about the benefits, clinical uses, dosing, and contraindications of this remarkable herb!

In this week's IMA Webinar, our experts discuss the relatively new concept of "Spike Protein Susceptibility." Join the study authors as they break down their vital research, revealing why COVID vaccine reactions can differ so dramatically.

'The IMA is one giant family—a group of honest teachers and eager learners, like me!' Josie, one of the amazing attendees at the IMA 2025 Conference, ‘Honest Medicine™: Redefining Health.’

Cancer diagnoses continue to rise—affecting younger people more than ever. Join IMA Chief Scientific Officer Dr. Paul Marik and IMA Senior Fellow Dr. Mollie James for a timely webinar focused on cancer, recurrence, and the research helping to make sense of this troubling trend.

Dr. Chris Martenson is joined by former Deputy Assistant Secretary of HHS David Mansdoerfer and special guests—Sen. Ron Johnson, and IMA Senior Fellow Dr. Jordan Vaughn—for a timely breakdown of the May 21, 2025, U.S. Senate hearing on COVID-19 vaccine development and safety.

The Independent Medical Alliance is proud to congratulate Dr. Mary Talley Bowden on being recognized for her frontline medical service in the Lone Star state.

A newly published review in the Journal of Independent Medicine presents compelling data from a southern California clinic that treated thousands of COVID-19 patients during the height of the pandemic—with outcomes that significantly outperformed regional and national trends.